The market dynamics for Dermatomyositis are witnessing significant growth driven by the increasing diagnosis of this rare autoimmune disease, rising awareness among healthcare professionals, expanding use of immunoglobulin and immunosuppressive therapies, and the development of targeted biologics and immunomodulators. Additionally, … Continue reading →

The market dynamics for Oral Mucositis is witnessing steady growth driven by the increasing incidence of cancer, rising utilization of chemotherapy and radiotherapy, growing awareness regarding supportive cancer care, and increasing research and development activities. Additionally, the launch of emerging … Continue reading →

The market dynamics for Gaucher Disease is witnessing steady growth driven by the increasing prevalence of the disease, improving diagnosis rates, growing adoption of enzyme replacement and substrate reduction therapies, and the emergence of innovative gene therapies. Additionally, the launch … Continue reading →